New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
16:36 EDTAGNFDA approves Botox to treat overactive bladder
The U.S. Food and Drug Administration expanded the approved use of Botox to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics. Botox’s safety and effectiveness for this new indication were established in two clinical trials of 1,105 patients with symptoms of overactive bladder. Patients were randomly assigned to receive injections of 100 units of Botox or placebo. Botox is manufactured by Allergan (AGN). Reference Link
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
January 13, 2015
14:00 EDTAGNActavis says Allergan deal could close as early as Q1, as late as Q2
Subscribe for More Information
07:39 EDTAGNAmerican Academy of Cosmetic Surgery to hold a meeting
Subscribe for More Information
January 12, 2015
09:37 EDTAGNSupreme Court rejects Allergan appeal on generic Latisse, Bloomberg reports
08:09 EDTAGNActavis and Allergan announce early termination of HSR waiting period
Subscribe for More Information
08:07 EDTAGNActavis, Allergan announce early termination of Hart Scott Rodino waiting period
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use